ArticleDrug design, development and therapy2022

Blockade of the P2Y2 Receptor Attenuates Alcoholic Liver Inflammation by Targeting the EGFR-ERK1/2 Signaling Pathway.

Zhen-Ni Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.